Hua Medicine (Shanghai) Ltd. reported consolidated earnings results for the six months ended June 30, 2020. For the period, the company reported net loss of RMB 173,455,000 or RMB 0.18 per basic and diluted share compared to RMB 235,500,000 or RMB 0.25 per basic and diluted share a year ago.